Pharmacovigilance in Australia: how do adverse event reports from clinicians contribute to medicine and vaccine safety?
Deborah Greenbaum, Stephanie Cheung, Claire Turner, Fiona Mackinnon, Claire Larter · 2024
Read Pharmacovigilance in Australia: how do adverse event reports from clinicians contribute to medicine and vaccine safety? by Deborah Greenbaum, Stephanie Cheung, Claire Turner, Fiona Mackinnon, Claire Larter (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11703569.txt.
Description
Five authors, led by Deborah Greenbaum, explain in 2024 how reports from doctors and nurses feed drug and vaccine safety work in Australia. Such reports can flag side effects that trials missed. Drug firms must report harms, while health staff and patients are urged to report, even when the link to a drug is unsure.
Reports on new drugs and on drugs under extra watch matter most, the authors note. So do severe or odd reactions to older drugs. The national agency scans all reports for fresh warning signals. Those signals can lead to rule changes and safety alerts for the public.
Catalog record
| CREATOR | Deborah Greenbaum, Stephanie Cheung, Claire Turner, Fiona Mackinnon, Claire Larter |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |